Screener
Phreesia PHR R&D
R&D at other companies
Other financials
Where this comes from
Reported directly by Phreesia in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The source filing: Phreesia’s 10-Q, filed May 28, 2026.
- Filed
- May 28, 2026, 4:01 PM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0001412408-26-000172
| Line item | Three months ended April 30, 2026 | Three months ended April 30, 2025 |
|---|---|---|
| Cost of revenue (excluding depreciation and amortization) | 17,659 | 16,637 |
| Payment solutions expense(1) | 25,675 | 21,428 |
| Sales and marketing | 24,209 | 26,043 |
| Research and development | 28,328 | 31,829 |
| General and administrative | 18,361 | 16,408 |
| Depreciation | 3,371 | 2,986 |
| Amortization | 6,583 | 3,892 |
| Total expenses | 124,186 | 119,223 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Phreesia's R&D?
- Phreesia (PHR) reported R&D of $28.33M in Q1 2026.
- How has Phreesia's R&D changed year-over-year?
- Phreesia's R&D decreased by 11.0% year-over-year, from $31.83M to $28.33M.
- What is the long-term trend for Phreesia's R&D?
- Over 4 years (2022 to 2026), Phreesia's R&D has grown at a 23.5% compound annual growth rate (CAGR), from $52.27M to $121.48M.
- What does R&D mean?
- Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.
Ask your AI about Phreesia's r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude